BVF GP HOLDINGS LLC
CIK 1803809 · last filed 2026-06-23
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
OLMA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN FRANCISCO, CA 94104
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OLMA | Director | 2,755,533 | $6.62 | $18.24M | $225.71M | 4 | 2026-06-23 |
| KYMR | Director | 294,632 | $114.84 | $33.84M | $154.35M | 3 | 2024-08-22 |
| MLTX | Director | 11,265,678 | $11.81 | $133.05M | $0 | 1 | 2023-06-12 |
| XOMA Royalty Corp (XOMAP) Delisted | Director | 1,818,637 | $24.98 | $45.43M | $4.09M | 2 | 2023-05-19 |
| Repare Therapeutics Inc. (RPTX) Delisted | 10%+ Owner | 2,969,742 | $2.65 | $7.87M | $218.59M | 1 | 2022-06-06 |
| Merus N.V. (MRUS) Delisted | 10%+ Owner | 3,803,152 | $90.00 | $342.28M | $99.89M | 3 | 2021-04-01 |
| IDYA | 1,642,186 | $32.88 | $54.00M | $8.54M | 2 | 2021-02-04 | |
| XOMA Royalty Corp (XOMA) Delisted | 10%+ Owner | 171,336 | $40.17 | $6.88M | $54.99M | 2 | 2020-12-15 |
| FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | 10%+ Owner | 541,116 | $38.00 | $20.56M | $1.2K | 1 | 2020-09-24 |
Recent Filings · Page 2 of 2
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-12-02 | OLMA | Buy (P) | +7,396,750 | $69.46M | EDGAR |
| 2021-04-01 | Merus N.V. (MRUS) Delisted | Buy (P) | +3,000,000 | $59.25M | EDGAR |
| 2021-03-24 | Merus N.V. (MRUS) Delisted | Buy (P) | +795,000 | $18.09M | EDGAR |
| 2021-02-04 | IDYA | Sell (S) | −464,090 | -$8.35M | EDGAR |
| 2020-12-15 | XOMA Royalty Corp (XOMA) Delisted | Buy (P) | +2,000,000 | $50.00M | EDGAR |
| 2020-09-24 | FIVE PRIME THERAPEUTICS, INC. (FPRX) Delisted | Buy (P) | +320 | $1.2K | EDGAR |
| 2020-09-08 | Merus N.V. (MRUS) Delisted | Buy (P) | +2,019,060 | $22.55M | EDGAR |
| 2020-08-14 | XOMA Royalty Corp (XOMA) Delisted | Buy (P) | +270,220 | $4.99M | EDGAR |
| 2020-06-22 | IDYA | Buy (P) | +1,179,960 | $16.89M | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.